OR WAIT null SECS
September 06, 2024
Viral vectors and other complex biologic modalities require more specificity and higher sensitivity to detect and distinguish contaminants.
August 06, 2024
Manual and automated inspection technologies have their own advantages and limitations.
July 13, 2024
Thermo Fisher will add Olink to its Life Sciences Solutions business.
July 05, 2024
Although advancements in analytical drug substance testing are being made, the increasing diversity of the therapeutic landscape is necessitating further innovation.
July 04, 2024
HCPs are major process-related impurities that must be monitored throughout biologics production for clearance.
June 11, 2024
A statistical analysis for determining an expiration date can be applied to replicates or their corresponding averages as suggested in industry guidelines.
June 06, 2024
Biosimilar analytical assessments focus on demonstrating biosimilarity and interchangeability with the reference biologic.
Founder and CEO of Atomic AI, Raphael Townshend, explores AI’s usefulness as a tool to characterize molecular structure and advance molecule engineering.
Andrew Carnegie, head of Strategic Commercial Development at Inaphaea BioLabs, discusses the establishment of translational CROs and the role of PDC models in the drug discovery process.
June 05, 2024
Lee Cronin, founder and CEO of Chemify, discusses the combination of digital chemistry, robotics, and AI in the drug discovery space.